Vadim Pokrovsky

Top papers

• Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

  Susan Swindells, Jaime Andrade‐Villanueva, Gary Richmond, et al.·2020·New England Journal of Medicine
  ↗ 551OA
• Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

  François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink, et al.·2013·The Lancet
  ↗ 545OA
• Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

  Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora, et al.·2020·New England Journal of Medicine
  ↗ 452OA
• HIV infection associated with drug injecting in the Newly Independent States, eastern Europe: the social and economic context of epidemics

  Tim Rhodes, Andrew Ball, Gerry V. Stimson, et al.·1999·Addiction
  ↗ 215
• Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

  Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin, et al.·2020·JAIDS Journal of Acquired Immune Deficiency Syndromes
  ↗ 144OA
• Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

  Jean‐Michel Molina, Kathleen Squires, Paul E. Sax, et al.·2018·The Lancet HIV
  ↗ 142
• Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

  Catherine Orrell, Debbie Hagins, Elena Belonosova, et al.·2017·The Lancet HIV
  ↗ 117
• Expert consensus statement on the science of <scp>HIV</scp> in the context of criminal law

  Françoise Barré‐Sinoussi, Salim S. Abdool Karim, Jan Albert, et al.·2018·Journal of the International AIDS Society
  ↗ 111OA
• A Sudden Epidemic of HIV Type 1 among Injecting Drug Users in the Former Soviet Union: Identification of Subtype A, Subtype B, and Novel <i>gag</i> A/ <i>env</i> B Recombinants

  Aleksei F. Bobkov, Elena Kazennova, LUDMILA SELIMOVA, et al.·1998·AIDS Research and Human Retroviruses
  ↗ 105
• Proposed World-Health-Organization Staging System for Hiv-Infection and Disease - Preliminary Testing by An International Collaborative Cross-Sectional Study

  Pedro Cahn, DA Cooper, B. Tindall, et al.·1992·AIDS
  ↗ 89
• An HIV Type 1 Epidemic among Injecting Drug Users in the Former Soviet Union Caused by a Homogeneous Subtype A Strain

  Aleksei F. Bobkov, Rachanee Cheingsong‐Popov, LUDMILA SELIMOVA, et al.·1997·AIDS Research and Human Retroviruses
  ↗ 87
• Temporal trends in the HIV‐1 epidemic in Russia: Predominance of subtype A

  Aleksei F. Bobkov, Elena Kazennova, LUDMILA SELIMOVA, et al.·2004·Journal of Medical Virology
  ↗ 81